Arformoterol
Arformoterol
Definition
A long-acting beta-2 adrenergic agonist and isomer of formoterol with bronchodilator activity. Arformoterol selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing stimulation of adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased intracellular cAMP levels cause relaxation of bronchial smooth muscle and lead to a reduced release of inflammatory mediators from mast cells. This may eventually lead to an improvement of airway function.
Also known as ARFORMOTEROL — per NCIT
Also identified as
- NCIT NCIT:C61641 per NCIT
- SCTID 423317005 per RXNORM
- SCTID 423347007 per RXNORM
- UNII F91H02EBWT per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Chronic bronchitis | may treat | MEDRT · Public domain (U.S. Government work) |
| Pulmonary emphysema | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Lungs | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Respiratory system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.